Relative risk reduction of death was 89% for molnupiravir when compared to placebo. Side effects were similar in the two groups with molnupiravir group having 35.0% and the placebo group had 39.6% of patients reporting side effects.
When testing thyroid function, most physicians order only TSH (thyroid stimulating hormone) and T4. But to have normal thyroid function several conditions must be met. Of those many conditions, three are often not considered by most physicians and not evaluated with TSH and T4. First, there mus...